Bulletin
Investor Alert

New York Markets After Hours

Zai Lab Ltd. ADR

NAS: ZLAB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202307458/composite

$

79.33

Change

0.00 0.00%

Volume

Volume 2,999

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202307458/composite

Today's close

$ 77.12

$ 79.33

Change

+2.21 +2.87%

Day low

Day high

$75.41

$81.33

Open
Open: 76.60

52 week low

52 week high

$29.43

$89.48

Open

Market cap

$6.63B

Average volume

325,523

P/E ratio

N/A

Rev. per Employee

$1,470

EPS

N/A

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/zlab

MarketWatch News on ZLAB

  1. Incyte enters license deal with Zai Lab for commercialization of Incyte's cancer treatment in China

    7:35 a.m. July 2, 2019

    - Tomi Kilgore

  2. Zai Lab stock price target cut to $33 from $43 at Leerink

    9:57 a.m. Aug. 24, 2018

    - Tomi Kilgore

  3. Zai Lab upgraded to overweight from neutral at J.P. Morgan

    9:16 a.m. Feb. 14, 2018

    - Tomi Kilgore

  4. Zai Lab started at outperform with $42 stock price target at Leerink

    9:26 a.m. Oct. 16, 2017

    - Tomi Kilgore

  5. Zai Lab started at neutral with $32 stock price target at J.P. Morgan

    7:58 a.m. Oct. 16, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/zlab

Other News on ZLAB

  1. Zai Lab prices Hong Kong listing at HK$562

    8:11 a.m. Sept. 22, 2020

    - Seeking Alpha

  2. Tracking Ron Baron's BAMCO Portfolio - Q2 2020 Update

    3:18 p.m. Sept. 21, 2020

    - Seeking Alpha

  3. Zai Lab' niraparib shows PFS benefit, compared to placebo

    11:12 a.m. Sept. 21, 2020

    - Seeking Alpha

  4. Wall Street Breakfast: The Week Ahead

    11:33 a.m. Sept. 20, 2020

    - Seeking Alpha

  5. Zai Lab launches Hong Kong secondary listing

    7:25 a.m. Sept. 16, 2020

    - Seeking Alpha

  6. Week In Review: Baidu Raising $2 Billion For New China Biopharma

    11:40 a.m. Sept. 13, 2020

    - Seeking Alpha

  7. Zai Lab's Zejula OK'd in China for first-line ovarian cancer

    8:04 a.m. Sept. 10, 2020

    - Seeking Alpha

  8. Zai Lab Limited 2020 Q2 - Results - Earnings Call Presentation

    8:59 a.m. Aug. 13, 2020

    - Seeking Alpha

  9. Zai Lab's NDA for ripretinib accepted in China

    8:59 a.m. July 20, 2020

    - Seeking Alpha

  10. Turning Point Therapeutics inks deal with Zai Lab for lead drug

    12:06 p.m. July 7, 2020

    - Seeking Alpha

  11. Tracking Ron Baron's BAMCO Portfolio - Q1 2020 Update

    7:03 p.m. June 14, 2020

    - Seeking Alpha

  12. ZLAB Investor Presentation - Slideshow

    4:23 p.m. June 12, 2020

    - Seeking Alpha

  13. Zai Lab (ZLAB) Investor Presentation - Slideshow

    4:23 p.m. June 12, 2020

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/zlab

Press Releases on ZLAB

  1. Zai Lab Announces Pricing of Hong Kong Secondary Listing

    7:53 a.m. Sept. 22, 2020

    - GlobeNewswire

  2. Zai Lab Announces Pricing of Hong Kong Secondary Listing

    7:53 a.m. Sept. 22, 2020

    - GlobeNewswire

  3. Zai Lab Launches Hong Kong Secondary Listing

    7:16 a.m. Sept. 16, 2020

    - GlobeNewswire

  4. Zai Lab Launches Hong Kong Secondary Listing

    7:15 a.m. Sept. 16, 2020

    - GlobeNewswire

  5. Zai Lab Appoints F. Ty Edmondson as Chief Legal Officer

    7:35 a.m. Aug. 17, 2020

    - GlobeNewswire

  6. Zai Lab Appoints F. Ty Edmondson as Chief Legal Officer

    7:30 a.m. Aug. 17, 2020

    - GlobeNewswire

  7. Loading more headlines...

Rates »

Link to MarketWatch's Slice.